Toggle Dropdown
Groups
Announcements
Projects
News & Events
Welcome guest
Log in
Friends
Loading
Loading...
https://arstechnica.com/science/2023/01/annual-bivalent-for-all-future-of-covid-shots-murky-after-fda-deliberations/
0
0
Annual? Bivalent? For all? Future of COVID shots murky after FDA deliberations - Ars Technica
1/27/23 at 11:12pm
Organization
Ars Technica
Author
Beth Mole
28 words
0
Comments
FDA seems sold on annual shots, but advisors call for a lot more data.
Business & Industrial
FDA
Ars Technica
COVID
You are the first to view
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...